1. 2020
  2. Фармакоэкономическая оценка ипраглифлозина в комбинации с метформином в сравнении с другими режимами терапии сахарного диабета 2 типа

    Колбин, А. С., Курылев, А. А., Балыкина, Ю. Е. & Проскурин, М. А., 2020, In: КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА. 5, p. 50-63

    Research output: Contribution to journalArticlepeer-review

  3. Фармакоэкономический анализ препарата тоцилизумаб при терапии пациентов с ревматоидным артритом и юношеским артритом с системным началом

    Колбин, А. С., Курылев, А. А., Мишинова, С. А., Балыкина, Ю. Е. & Проскурин, М. А., 2020, In: КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА. 1, p. 23-34 12 p.

    Research output: Contribution to journalArticlepeer-review

  4. 2019
  5. Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma

    Kolbin, A. S., Avdeev, S. N., Zhuravleva, M. V., Gomon, Y. M., Balykina, Y. E., Matveyev, N. V., Proskurin, M. A. & Fedosenko, S. V., 15 Dec 2019, In: Terapevticheskii Arkhiv. 91, 12, p. 47-56 10 p.

    Research output: Contribution to journalArticlepeer-review

  6. Distributed Tracking via Simultaneous Perturbation Stochastic Approximation-based Consensus Algorithm

    Erofeeva, V., Granichin, O., Amelina, N., Ivanskiy, Y. & Jiang, Y., Dec 2019, 2019 IEEE 58th Conference on Decision and Control, CDC 2019. Institute of Electrical and Electronics Engineers Inc., p. 6050-6055 6 p. 9030129. (IEEE Conference on Decision and Control).

    Research output: Chapter in Book/Report/Conference proceedingConference contributionResearchpeer-review

  7. Moving Information Horizon Approach for Dynamic Game Models

    Petrosian, O., Shi, L., Li, Y. & Gao, H., Dec 2019, In: Mathematics. 7, 12, 31 p., 1239.

    Research output: Contribution to journalArticlepeer-review

  8. CLINICAL AND ECONOMIC ASSESSMENT OF THE IMPORTANCE OF SUPPORTIVE THERAPY IN ONCOLOGY

    Kolbin, A., Velum, I., Balykina, Y. & Proskurin, M., Nov 2019, In: Value in Health. 22, S3, p. S504

    Research output: Contribution to journalMeeting Abstractpeer-review

  9. PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

    Kolbin, A., Vilum, I., Balykina, Y. & Proskurin, M., Nov 2019, In: Value in Health. 22, p. S510-S510 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. PHARMACOECONOMIC ANALYSIS OF RESLIZUMAB USE IN SEVERE ATOPIC ASTHMA WITH EOSINOPHILIA

    Kolbin, A., Gomon, J., Balykina, Y. & Proskurin, M., Nov 2019, In: Value in Health. 22, p. S874-S874 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  11. PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    Kolbin, A., Vilum, I., Balykina, Y. & Proskurin, M., Nov 2019, In: Value in Health. 22, p. S501-S501 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

ID: 29533